TELA Bio (TELA) Receivables - Net (2018 - 2026)

TELA Bio's Receivables - Net history runs 9 years deep, the most recent figure standing at $9.7 million for Q1 2026.

• In Q1 2026, Receivables - Net fell 7.98% year-over-year to $9.7 million; the TTM figure through Mar 2026 stood at $9.7 million (down 7.98% YoY), while the FY2025 annual figure was $10.3 million, up 2.47% from the prior year.
• Receivables - Net was $9.7 million for Q1 2026 at TELA Bio, down from $10.3 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $11.3 million in Q3 2025 to a low of $4.3 million in Q1 2022.
• Historically, Receivables - Net has averaged $8.7 million across 5 years, with a median of $9.7 million in 2026.
• The sharpest annual moves came in 2022 and 2026: Receivables - Net jumped 59.19% in 2022, then retreated 7.98% in 2026.
• A 5-year view of Receivables - Net shows it stood at $6.6 million in 2022, then jumped by 47.06% to $9.7 million in 2023, then grew by 3.71% to $10.1 million in 2024, then gained by 2.47% to $10.3 million in 2025, then decreased by 6.11% to $9.7 million in 2026.
• The last three Receivables - Net figures came in at $9.7 million (Q1 2026), $10.3 million (Q4 2025), and $11.3 million (Q3 2025), per Business Quant data.